Article
SynergEyes, Inc., has announced that its proprietary hybrid contact lens for irregular corneas has been prescribed to more than 16,000 patients in 32 countries since it became available in late 2009.
Carlsbad, CA-SynergEyes, Inc., has announced that its proprietary hybrid contact lens for irregular corneas (ClearKone) has been prescribed to more than 16,000 patients in 32 countries since it became available in late 2009.
The lens is available in North America and parts of The Americas, and in countries in Europe, the European Union, and the Middle East, as well as in Australia, England, Hong Kong, New Zealand, and South Africa.
According to SynergEyes, the proprietary contact lens was developed to fit a broad spectrum of patients with irregular corneas, including patients who have emerging-to-advanced keratoconus; central, oval and decentered cones; ectasia induced by radial keratotomy, photorefractive keratotomy, or LASIK; those who have undergone corneal collagen cross-linking or placement of corneal implants; and some cases of globus keratoconus and pellucid marginal degeneration.